Kenneth J Kelley

HALO

Kenneth J Kelley serves as Director at Halozyme Therapeutics, Inc. (HALO). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$451.7K

Net Position

Net Seller

$451.7K

Companies Traded

HALO

Active Period

Mar 2021 – Apr 2021

2 total trades

Most Recent

Sell HALO

Apr 14, 2021 · $225.0K

Kenneth J Kelley's Insider Trading at Halozyme Therapeutics, Inc. (HALO)

Buys

0 · $0.00

Sells

2 · $451.7K

Total Shares Bought

Total Shares Sold

10,000

HALO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Apr 14, 2021↗	Sell	5,000	$45.00	$225.0K	179,833
Mar 1, 2021↗	Sell	5,000	$45.34	$226.7K	185,333

Related Insiders

Cortney Caudill

officer: SVP, CHIEF OPERATING OFFICER

HALOSell · Mar 10, 2026

Helen Torley

director, officer: PRESIDENT AND CEO

HALOSell · Mar 4, 2026

Helen Torley

PRESIDENT AND CEO

HALOSell · Feb 16, 2026

Nicole LaBrosse

SVP, CHIEF FINANCIAL OFFICER

HALOSell · Feb 16, 2026

Mark Howard Snyder

SVP, CHIEF LEGAL OFFICER

HALOSell · Feb 16, 2026

Bernadette Connaughton

director

HALOSell · Jan 5, 2026

Bernadette Connaughton

Director

HALOSell · Dec 1, 2025

Bernadette Connaughton

HALOSell · Oct 1, 2025

Explore More Insider Trading Data

HALO Insider Trading Activity

View all insider trades at Halozyme Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity